STOCK TITAN

0913693 B.C. (REPCF) Stock Price, News & Analysis

REPCF OTC
Published by Stock Titan Data refreshed

What Changed

Price Move History

Daily moves over 5%
0 9 sessions, September 8, 2025 to September 14, 2026
Largest daily move
+0% close of November 3, 2025
1-year change
+0% closing prices, September 8, 2025 to September 14, 2026

Company Description

0913693 B.C. (OTC: REPCF) is classified in the biotechnology industry within the Healthcare sector and carries a market capitalization of $7.4K.

REPCF has gained 0.0% over the past year. The last closing price was $0.0001.

For FY2022, 0913693 B.C. reported net income of -$549K and diluted earnings per share of -$0.01.

This page collects what Stock Titan holds for REPCF, including price data, latest news, financial highlights, and short interest trends.

Stock Performance

$—
-
-
Last updated:
+0%
Performance 1 year

0913693 B.C. (REPCF) closed at $0.0001 on September 14, 2026. Over the past 12 months, the price has gained 0.0%.

See what a $1,000 investment in REPCF would be worth today

Average down calculator for REPCF

REPCF Metrics & Rankings

Price returns through September 14, 2026. Month-to-date and YTD include the first trading day. Ranking links may use different dates.

SEC Filings

No SEC filings available for REPCF.

Financial Highlights

operating income reached -$1.0M, and net income was -$549K. Diluted earnings per share stood at -$0.01. The company generated -$1.0M in operating cash flow. The current ratio was 0.31, measuring current assets divided by current liabilities.

-$549K
Net Income (FY2022)
-$1.0M
Operating Cash Flow
—
Revenue (FY2022)

Upcoming Events

Short Interest History

Last 12 Months

Short interest in 0913693 B.C. (REPCF) currently stands at 250 shares, representing 0.0% of the float.

Days to Cover History

Last 12 Months

Days to cover for 0913693 B.C. (REPCF) currently stands at 1000.0 days, up 99899% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.

REPCF Company Profile & Sector Positioning

0913693 B.C. (REPCF) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing REPCF often look at related companies in the same sector, including STATERA BIOPHARMA INC (STAB), RENOVACARE INC (RCAR), NOVACCESS GLOBAL INC (XSNX), COMERA LIFE SCIENCES HLDG (CMRA), and EVELO BIOSCIENCES INC (EVLO). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate REPCF's relative position within its industry.

Frequently Asked Questions

What is the current stock price of 0913693 B.C. (REPCF)?

The current stock price of 0913693 B.C. (REPCF) is $0.0001 as of October 19, 2026.

What is the market cap of 0913693 B.C. (REPCF)?

The market cap of 0913693 B.C. (REPCF) is approximately $7.4K. Learn more about what market capitalization means .

What is the net income of 0913693 B.C. (REPCF)?

The FY2022 net income of 0913693 B.C. (REPCF) is -$549K, from its most recent completed fiscal year.

What is the earnings per share (EPS) of 0913693 B.C. (REPCF)?

The diluted earnings per share (EPS) of 0913693 B.C. (REPCF) is -$0.01 for FY2022, its most recent completed fiscal year. Learn more about EPS .

What is the operating cash flow of 0913693 B.C. (REPCF)?

The operating cash flow of 0913693 B.C. (REPCF) is -$1.0M for FY2022, its most recent completed fiscal year. Learn about cash flow.

What is the current ratio of 0913693 B.C. (REPCF)?

The current ratio of 0913693 B.C. (REPCF), current assets divided by current liabilities, was 0.31 at the end of FY2022, its most recent completed fiscal year. Learn about liquidity ratios.

What is the operating income of 0913693 B.C. (REPCF)?

The operating income of 0913693 B.C. (REPCF) is -$1.0M for FY2022, its most recent completed fiscal year. Learn about operating income.